Concepedia

ENETS Consensus Guidelines for the Management of Patients with Neuroendocrine Neoplasms from the Jejuno-Ileum and the Appendix Including Goblet Cell Carcinomas

Ulrich‐Frank Pape, Aurel Perren, Bruno Niederle, David J. Gross, Thomas M. Gress, Frederico Costa, Rudolf Arnold, Timm Denecke, Ursula Plöckinger, Ramón Salazar,

Neuroendocrinology · 2012 · 462 citations · 149 references

DOIFull text

Open access

Concepts

Abstract

however, is covered in this chapter, since early recognition and treatment is important for this complication of carcinoid syndrome.

References

149

A 5‐decade analysis of 13,715 carcinoid tumors

Irvin M. Modlin, Kevin D. Lye, Mark Kidd · Cancer · 2003 · 2.7K citations

, , +10

Treatment With the Radiolabeled Somatostatin Analog [ <sup>177</sup> Lu-DOTA <sup>0</sup> ,Tyr <sup>3</sup> ]Octreotate: Toxicity, Efficacy, and Survival

Dik J. Kwekkeboom, Wouter W. de Herder, Boen L.R. Kam et al. · Journal of Clinical Oncology · 2008 · 1.4K citations · Full text

, , +17

Pathology and genetics

J. N. Eble · Medical Entomology and Zoology · 2004 · 1.1K citations

Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study

Marianne Pavel, John D. Hainsworth, Éric Baudin et al. · The Lancet · 2011 · 1.1K citations

, , +16

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

Michael Gabriel, Clemens Decristoforo, Dorota Kendler et al. · Journal of Nuclear Medicine · 2007 · 1K citations · Full text

, , +17